These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24989832)

  • 1. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
    Chandrasekharan S; McGuire AL; Van den Veyver IB
    Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.
    Matthews KR; Cuchiara ML
    Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
    Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
    J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Something more is necessary: are genes and genetic diagnostic tests statutory subject matter for US patents?
    Cockbain J; Sterckx S
    Expert Rev Mol Diagn; 2011 Mar; 11(2):149-58. PubMed ID: 21405966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The History of Patenting Genetic Material.
    Sherkow JS; Greely HT
    Annu Rev Genet; 2015; 49():161-82. PubMed ID: 26442843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continental drift? Do European clinical genetic testing laboratories have a patent problem?
    Liddicoat J; Liddell K; McCarthy AH; Hogarth S; Aboy M; Nicol D; Patton S; Hopkins MM
    Eur J Hum Genet; 2019 Jul; 27(7):997-1007. PubMed ID: 30846855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of Myriad and Mayo: will advancements in the biological sciences be spurred or disincentivized? (Or was biotech patenting not complicated enough?).
    Gordon J
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a020917. PubMed ID: 25502748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supreme Court ruling broadens BRCA testing options.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Nov; 105(22):1671-2. PubMed ID: 24198329
    [No Abstract]   [Full Text] [Related]  

  • 10. U.S. Supreme Court decision paves way for better genetic testing: ruling bars exclusive licensing, patents on naturally occurring genes.
    Levenson D
    Am J Med Genet A; 2013 Sep; 161A(9):ix-x. PubMed ID: 23946205
    [No Abstract]   [Full Text] [Related]  

  • 11. LabCorp v. Metabolite Laboratories: The Supreme Court listens, but declines to speak.
    Klein RD; Mahoney MJ
    J Law Med Ethics; 2008; 36(1):141-9, 4. PubMed ID: 18315767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene patenting--the Supreme Court finally speaks.
    Kesselheim AS; Cook-Deegan RM; Winickoff DE; Mello MM
    N Engl J Med; 2013 Aug; 369(9):869-75. PubMed ID: 23841703
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequenom v. Ariosa - The Death of a Genetic Testing Patent.
    Cook-Deegan R; Chandrasekharan S
    N Engl J Med; 2016 Dec; 375(25):2418-2419. PubMed ID: 28002697
    [No Abstract]   [Full Text] [Related]  

  • 14. Prometheus: the Supreme Court redefines the patentability of diagnostic inventions.
    Kumamoto A; Schmid CL
    Recent Pat DNA Gene Seq; 2012 Dec; 6(3):193-6. PubMed ID: 22812581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The continuing saga of patents and non-invasive prenatal testing.
    Hawkins N; Nicol D; Chandrasekharan S; Cook-Deegan R
    Prenat Diagn; 2019 May; 39(6):441-447. PubMed ID: 30900262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseball bats and chocolate chip cookies: the judicial treatment of DNA in the myriad genetics litigation.
    Binnie I; Park-Thompson V
    Cold Spring Harb Perspect Med; 2014 Dec; 5(6):. PubMed ID: 25524722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supreme Court rules against gene patents.
    Kuehn BM
    JAMA; 2013 Jul; 310(4):357-9. PubMed ID: 23917268
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent portfolios after myriad, how to fit in those new genes?
    Aceto JF
    ACS Med Chem Lett; 2013 Aug; 4(8):681-3. PubMed ID: 24900729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Court ruling invalidates patent on noninvasive test for down syndrome: decision cites landmark Supreme Court ruling in Myriad Genetics case.
    Am J Med Genet A; 2014 Feb; 164A(2):xi. PubMed ID: 24449203
    [No Abstract]   [Full Text] [Related]  

  • 20. Patenting a living microbial cell: 40th anniversary of US Supreme Court decision Diamond versus Chakrabarty.
    Silver S
    FEMS Microbiol Lett; 2020 Jul; 367(13):. PubMed ID: 32501475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.